Articles Tagged With:
-
Reanimation Study a Step Toward Brain-death Breakthrough?
A new reanimation study of brain death has many compelling and hopeful aspects to its principal investigator in India and biotech sponsor in the U.S.
-
Take a Multidisciplinary, Team-based Approach on Elder Abuse
New research suggests there is ample room for improvement in the way elder abuse is identified and managed, particularly in the emergency setting.
-
These Strategies Will Improve Care Transitions for Elderly Patients
Care transition for elderly patients is fraught with hidden obstacles and risks. Experienced case managers can identify and prevent problems.
-
Avoid These Common Pitfalls in Care Transitions
Transitions of care can be difficult if case managers fail to prepare for some of the more common obstacles and problems.
-
Tips for Handling Suspected Cases of Trafficking
Every healthcare system should have a protocol and system for handling suspected trafficking victims, according to a speaker and expert on the subject.
-
Red Flags That a Patient is a Victim of Trafficking
Victims of trafficking potentially could meet any healthcare professional, including case managers.
-
Human Trafficking is a Problem for Case Managers and All HCWs
Many U.S. healthcare professionals have met or treated a trafficking victim at some point in their careers, but they may not have recognized the signs.
-
Foreign Bodies of the Head and Neck
MONOGRAPH: Diagnosing and managing ear, nose, and throat foreign bodies with discussion separated by location.
-
Endocrine-disrupting Chemicals and Female Reproductive Disorders
The endocrine-disrupting chemicals diphenyl-dichloroethene and phthalates appear to contribute substantially to the incidence of the most common reproductive disorders in women, endometriosis and fibroids, and lead to total costs of 1.5 billion euros in the European Union.
-
Still Highly Effective: LNG IUS 52 mg at 7 Years
Data from a large randomized study conducted by the World Health Organization demonstrate that pregnancy rates do not increase after year five, and support the continued use of the levonorgestrel intrauterine system 52 mg for contraception through seven years.